{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:20:44Z","timestamp":1774394444523,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.urolonc.2013.06.012","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T17:30:20Z","timestamp":1382031020000},"page":"46.e19-46.e27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Human papillomaviruses in urological malignancies: A critical assessment"],"prefix":"10.1016","volume":"32","author":[{"given":"Yanis","family":"Tolstov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Pahernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Duensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.urolonc.2013.06.012_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1016\/j.urolonc.2013.06.012_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/ijc.23679","article-title":"Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.urolonc.2013.06.012_bib3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers\u2014a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.urolonc.2013.06.012_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.coviro.2012.05.004","article-title":"Cancer associated human papillomaviruses","volume":"2","author":"McLaughlin-Drubin","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-1702(02)00190-9","article-title":"Human papillomavirus immortalization and transformation functions","volume":"89","author":"Munger","year":"2002","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/QCO.0b013e328334c0e1","article-title":"Prospects for new human papillomavirus vaccines","volume":"23","author":"Stanley","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"14","key":"10.1016\/j.urolonc.2013.06.012_bib9","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/JVI.74.14.6622-6631.2000","article-title":"The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle","volume":"74","author":"Flores","year":"2000","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0891-5520(20)30624-3","article-title":"Human papillomaviruses","volume":"8","author":"McCance","year":"1994","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.urolonc.2013.06.012_bib11","doi-asserted-by":"crossref","first-page":"e39632","DOI":"10.1371\/journal.pone.0039632","article-title":"Non-random integration of the HPV genome in cervical cancer","volume":"7","author":"Schmitz","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/epr.12.13","article-title":"Biomarkers for cervical cancer screening: the role of p16 (INK4a) to highlight transforming HPV infections","volume":"9","author":"von Knebel Doeberitz","year":"2012","journal-title":"Expert Rev Proteomics"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/infdis\/jir248","article-title":"Human papillomavirus infection and bladder cancer risk: a meta-analysis","volume":"204","author":"Li","year":"2011","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.urolonc.2013.06.012_bib14","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jcv.2004.12.004","article-title":"Molecular diagnosis of human papillomavirus (HPV) infections","volume":"32","author":"Molijn","year":"2005","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.urolonc.2013.06.012_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/scbi.1999.0146","article-title":"The serological response to papillomaviruses","volume":"9","author":"Dillner","year":"1999","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"10.1016\/j.urolonc.2013.06.012_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrc2961","article-title":"Why do viruses cause cancer? Highlights of the first century of human tumour virology","volume":"10","author":"Moore","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.urolonc.2013.06.012_bib17","first-page":"872","article-title":"Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study","volume":"12","author":"Adami","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.urolonc.2013.06.012_bib18","first-page":"506","article-title":"Prostate cancer and sexually transmitted diseases: a meta-analysis","volume":"37","author":"Taylor","year":"2005","journal-title":"Fam Med"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.epirev.a000781","article-title":"Sexual behavior and evidence for an infectious cause of prostate cancer","volume":"23","author":"Strickler","year":"2001","journal-title":"Epidemiol Rev"},{"issue":"12","key":"10.1016\/j.urolonc.2013.06.012_bib20","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/1055-9965.EPI-05-0602","article-title":"Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study","volume":"14","author":"Korodi","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.urolonc.2013.06.012_bib21","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1055-9965.EPI-07-0134","article-title":"Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study","volume":"16","author":"Sutcliffe","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1158\/1055-9965.EPI-09-1080","article-title":"Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention trial","volume":"19","author":"Sutcliffe","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0165-4608(97)00207-0","article-title":"Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA","volume":"99","author":"Weijerman","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib24","first-page":"823","article-title":"Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers","volume":"59","author":"Serth","year":"1999","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0090-4295(97)00126-X","article-title":"Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized","volume":"50","author":"Terris","year":"1997","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<117::AID-PROS7>3.0.CO;2-D","article-title":"Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males","volume":"28","author":"Wideroff","year":"1996","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.urolonc.2013.06.012_bib27","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/S0022-5347(17)37040-4","article-title":"Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization","volume":"148","author":"Ibrahim","year":"1992","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0022-5347(17)38476-8","article-title":"High prevalence of human papillomavirus in prostate tissues","volume":"145","author":"McNicol","year":"1991","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2013.06.012_bib29","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jmv.23367","article-title":"HPV persistence and its oncogenic role in prostate tumors","volume":"84","author":"Tachezy","year":"2012","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0022-5347(17)37195-1","article-title":"Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction","volume":"147","author":"Effert","year":"1992","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2013.06.012_bib31","first-page":"633","article-title":"Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies","volume":"30","author":"Gazzaz","year":"2009","journal-title":"Saudi Med J"},{"issue":"3","key":"10.1016\/j.urolonc.2013.06.012_bib32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1054\/bjoc.1999.0986","article-title":"Sexual behaviour, STDs and risks for prostate cancer","volume":"82","author":"Hayes","year":"2000","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2013.06.012_bib33","first-page":"763","article-title":"Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer","volume":"12","author":"Rosenblatt","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","article-title":"Penile cancer: epidemiology, pathogenesis and prevention","volume":"27","author":"Bleeker","year":"2009","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2013.06.012_bib35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/bjc.1980.66","article-title":"Mortality of wives of men dying with cancer of the penis","volume":"41","author":"Smith","year":"1980","journal-title":"Br J Cancer"},{"issue":"46","key":"10.1016\/j.urolonc.2013.06.012_bib36","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1016\/j.vaccine.2012.08.034","article-title":"Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium","volume":"30","author":"D'Hauwers","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2012.05.029","article-title":"Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16 (INK4a) expression, and prognosis","volume":"68","author":"Ferrandiz-Pulido","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S0074-02762012000100003","article-title":"Prevalence of human papillomavirus and Epstein-Barr virus DNA in penile cancer cases from Brazil","volume":"107","author":"Afonso","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","article-title":"Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis","volume":"159","author":"Rubin","year":"2001","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2013.06.012_bib40","first-page":"1934","article-title":"Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites","volume":"61","author":"Carter","year":"2001","journal-title":"Cancer Res"},{"issue":"29","key":"10.1016\/j.urolonc.2013.06.012_bib41","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2007.12.3182","article-title":"Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma","volume":"25","author":"Heidemann","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2013.06.012_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.mi.48.100194.002235","article-title":"Human papillomaviruses","volume":"48","author":"zur Hausen","year":"1994","journal-title":"Annu Rev Microbiol"},{"issue":"10","key":"10.1016\/j.urolonc.2013.06.012_bib43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jmv.20703","article-title":"The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand","volume":"78","author":"Senba","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.urolonc.2013.06.012_bib44","article-title":"Combining routine morphology, p16 immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses","author":"Chaux","year":"2013","journal-title":"Urol Oncol"},{"issue":"7109","key":"10.1016\/j.urolonc.2013.06.012_bib45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bmj.315.7109.646","article-title":"Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers","volume":"315","author":"Bjorge","year":"1997","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.urolonc.2013.06.012_bib46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.urolonc.2013.06.012_bib47","doi-asserted-by":"crossref","first-page":"812368","DOI":"10.1155\/2011\/812368","article-title":"The strong protective effect of circumcision against cancer of the penis","volume":"2011","author":"Morris","year":"2011","journal-title":"Adv Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2013.06.012_bib48","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/ijc.26196","article-title":"Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men","volume":"130","author":"Backes","year":"2012","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2013.06.012_bib49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/sextrans-2012-050633","article-title":"Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda","volume":"89","author":"Wilson","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.urolonc.2013.06.012_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.28100","article-title":"Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda","author":"Davis","year":"2013","journal-title":"Int J Cancer"},{"issue":"218","key":"10.1016\/j.urolonc.2013.06.012_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/03008880802285032","article-title":"The global burden of urinary bladder cancer","author":"Parkin","year":"2008","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"20","key":"10.1016\/j.urolonc.2013.06.012_bib52","first-page":"4823","article-title":"High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder","volume":"53","author":"Furihata","year":"1993","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2006.11.017","article-title":"Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer","volume":"52","author":"Moonen","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib54","first-page":"155","article-title":"Longitudinal study of human papillomavirus infection of the female urogenital tract by in situ hybridization","volume":"114","author":"Wilson","year":"1990","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.urolonc.2013.06.012_bib55","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/jcp.50.12.1018","article-title":"Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction","volume":"50","author":"Chan","year":"1997","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2013.06.012_bib56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002400050107","article-title":"Low frequency of human papillomavirus infection in initial papillary bladder tumors","volume":"27","author":"Simoneau","year":"1999","journal-title":"Urol Res"},{"issue":"10","key":"10.1016\/j.urolonc.2013.06.012_bib57","first-page":"232","article-title":"Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients","volume":"10","author":"Badawi","year":"2008","journal-title":"Medscape J Med"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jcp.2004.017152","article-title":"Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis","volume":"58","author":"Youshya","year":"2005","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2013.06.012_bib59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0090-4295(94)80202-5","article-title":"Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses","volume":"44","author":"Noel","year":"1994","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/bjc.2011.519","article-title":"Urinary human polyomavirus and papillomavirus infection and bladder cancer risk","volume":"106","author":"Polesel","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00300263","article-title":"Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder","volume":"20","author":"Knowles","year":"1992","journal-title":"Urol Res"},{"issue":"11","key":"10.1016\/j.urolonc.2013.06.012_bib62","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/modpathol.2012.103","article-title":"p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma","volume":"25","author":"Alexander","year":"2012","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.urolonc.2013.06.012_bib63","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/modpathol.2012.112","article-title":"Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection","volume":"25","author":"Blochin","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib64","first-page":"53","article-title":"Role of viruses in renal cell carcinoma","volume":"23","author":"Salehipoor","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.pai.0000205059.42421.cb","article-title":"Human papillomavirus DNA and P16INK4A are not detected in renal tumors with immunohistochemistry and signal-amplified in situ hybridization in paraffin-embedded tissue","volume":"14","author":"Hodges","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"10.1016\/j.urolonc.2013.06.012_bib66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/gyno.2000.5942","article-title":"HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients","volume":"79","author":"Brown","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2013.06.012_bib67","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.transproceed.2008.05.074","article-title":"Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients","volume":"40","author":"Paternoster","year":"2008","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.urolonc.2013.06.012_bib68","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1128\/jvi.65.6.3335-3339.1991","article-title":"Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice","volume":"65","author":"Kondoh","year":"1991","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.urolonc.2013.06.012_bib69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00008469-199808000-00006","article-title":"A survey of human papillomavirus 16 antibodies in patients with epithelial cancers","volume":"7","author":"Strickler","year":"1998","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"10.1016\/j.urolonc.2013.06.012_bib70","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/BF02234568","article-title":"High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice","volume":"44","author":"Goldstone","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib71","first-page":"1","article-title":"Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe","volume":"22","author":"Skamperle","year":"2013","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"issue":"6","key":"10.1016\/j.urolonc.2013.06.012_bib72","first-page":"950","article-title":"Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections","volume":"74","author":"Ferenczy","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.urolonc.2013.06.012_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.lgt.0000229565.19364.cc","article-title":"Autoclave sterilization of instruments used on women with cervical neoplasia is an effective method of eradicating residual human papillomavirus DNA: a polymerase chain reaction-based evaluation","volume":"11","author":"Estes","year":"2007","journal-title":"J Low Genit Tract Dis"},{"issue":"19","key":"10.1016\/j.urolonc.2013.06.012_bib74","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.vaccine.2013.03.006","article-title":"Estimating the long-term effects of HPV vaccination in Germany","volume":"31","author":"Horn","year":"2013","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.urolonc.2013.06.012_bib75","first-page":"569","article-title":"Human papilloma viruses and cancer","author":"zur Hausen","year":"1975","journal-title":"Bibl Haematol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913002822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913002822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:08Z","timestamp":1761041048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913002822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1078143913002822"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.06.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomaviruses in urological malignancies: A critical assessment","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}